New Approach Methodologies (NAMs) Archives

Blog

AI in Alzheimer’s drug development: Where do disease-modifying interventions go from here?

Explore how AI-enabled QSP and model-informed drug development are reshaping Alzheimer’s disease-modifying therapies, from amyloid…

CertaraFebruary 2, 2026

Webinar

Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy

CertaraJanuary 22, 2026

Guide

New Approach Methodologies (NAMs): By the numbers

We outline today’s animal-use landscape, the rise of NAMs, & how the Non-Animal Navigator supports…

CertaraDecember 10, 2025

Podcast Press Coverage

New Approach Methodologies: Redefining Animal Testing Alternatives

Explore how New Approach Methodologies (NAMs) and advanced in silico and in vitro tools are…

CertaraDecember 10, 2025

Guide

A Guide to the FDA Announcement to Phase Out Animal Testing for Drugs

The FDA is phasing out animal testing of new drugs. Learn how Certara’s Non-Animal Navigator™…

CertaraNovember 17, 2025

Announcement

Certara Study Shows Half of Americans Unaware of FDA/NIH Move to Phase Out Animal Testing of New Drugs

Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…

CertaraNovember 12, 2025

Publication

Towards new approach methodologies for biological therapeutics: a novel model-informed metric to assess immunogenicity risk

Immunogenicity poses a significant challenge in biotherapeutics development due to the formation of anti-drug antibodies…

Danielle PillsburyNovember 7, 2025

On-Demand Webinar

In silico Safety and Toxicology assessment: ToxStudio®

Discover how Certara’s ToxStudio align with FDA’s roadmap to reduce animal testing and transform preclinical…

CertaraOctober 30, 2025

Press Coverage

Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research

The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…

Danielle PillsburySeptember 10, 2025

Press Coverage

AI-driven drug discovery picks up as FDA pushes to reduce animal testing

AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…

CertaraSeptember 9, 2025

New Approach Methodologies (NAMs)